Gerresheimer AG (ETR:GXI)
29.04
+1.10 (3.94%)
Oct 24, 2025, 5:35 PM CET
Gerresheimer AG Employees
Gerresheimer AG had 12,142 employees as of November 30, 2024. The number of employees increased by 482 or 4.13% compared to the previous year.
Employees
12,142
Change (1Y)
482
Growth (1Y)
4.13%
Revenue / Employee
€166,255
Profits / Employee
€1,725
Market Cap
1.00B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | 12,142 | 482 | 4.13% |
| Nov 30, 2023 | 11,660 | 598 | 5.41% |
| Nov 30, 2022 | 11,062 | 615 | 5.89% |
| Nov 30, 2021 | 10,447 | 567 | 5.74% |
| Nov 30, 2020 | 9,880 | 8 | 0.08% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
Gerresheimer AG News
- 22 hours ago - Gerresheimer finds 2024 revenue-recognition issues after external probe - Reuters
- 1 day ago - Gerresheimer AG Probed for 2024 Revenue Practices - Wallstreet:Online
- 1 day ago - EQS-Adhoc: Gerresheimer AG: Initial findings of an external independent investigation into revenue recognition from bill-and-hold agreements in the 2024 financial year - Wallstreet:Online
- 12 days ago - EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 12 days ago - EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 12 days ago - EQS-DD: Gerresheimer AG: Dietmar Siemssen, buy - Wallstreet:Online
- 13 days ago - EQS-News: Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix ONYU* - Wallstreet:Online
- 16 days ago - Gerresheimer AG (GRRMF) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - GuruFocus